Infectious Diseases In Pregnancy Flashcards
U.K. prevalence of TB
4.2 per 100, 000
World wide prevalence of TB in pregnant women
0.25% low prevalence country
0.5% high prevalence country
11% in HIV positive women
Mycobacterium tuberculosis organism characteristics
Aerobic
Non-spore forming
Non-motile bacillus
Primary TB
Disease within 2 years of infection
Latent TB
Asymptomatic and non-infectious
Sites of extra pulmonary disease in pregnancy
Cervical lymph nodes (31%)
CNS
abdomen
Pericardium
Effects of TB on perinatal outcomes
Low APGAR
RDS with extra pulmonary disease
Preterm delivery
SGA
Oligohydramnios
PPROM
Effects of TB on maternal outcomes
Hypertension
Cholestasis
GDM
Anaemia
Death
Associations with HIV-TB coinfection
Anaemia
Eclampsia
Placenta accepts
Drug abuse
Depression
Treatment of TB (no CNS involvement)
Initial phase (2 months) - rifampicin, isoniazid, ethambutol and pyrazinamide
Continuation phase (4 months) - rifampicin and isoniazid
*give pyridoxine
Treatment of TB with CNS involvement
Rifampicin, isoniazid, pyrazinamide and ethambutol for 2 months
Rifampicin and isoniazid for 10 months
Dexamethasone/prednisone for 4-8 weeks
*Give pyridoxine
Treatment of drug resistant TB
Continue 3 drug treatment for 2 months followed by continuation with sensitive agents for 4-7 months
Most common infective site of TB in the neonate
Liver
Diagnostic tests for perinatal TB
Placental histology and culture
CXR
CSF culture
GI/tracheal aspirated
Presentation of perinatal TB
RDS
Failure to thrive
Irritability
Lymphadenopathy
Pyrexia of unknown origin
Unexplained anaemia
Hepatosplemomegaly
Perinatal TB mortality
22% treated infants
38% non-treated infants
Breastfeeding in TB
Safe after completion of 2 weeks Rx
Not safe if multi-drug resistant or HIV coinfection
BGC vaccination recommendation
If neonate is in a high prevalence area 40/10000
If close relatives are from high incidence countries (40/100000)
If born to HIV mum, formula fed and HIV negative at 14 weeks
Commonest causative organisms for obstetric sepsis
Streptococcal groups A, B, D
Pneumococcus
E. coli
Septic shock management
If lactate >4 or hypotension is present then:
30ml/kg crystalloid within 3 hours of diagnosis
Vasopressor or inotrope to maintain MAP 65mmHg
Measure cardiac output with oesophageal Doppler or lithium dilution cardiac output (LiDCO)
Consider steroids if inadequate response to vasopressors
Remove septic focus
Thromboprophylaxis
+/- blood products
Who gets offered IAP for GBS
Preterm labour
GBS colonisation during current pregnancy
Previous baby with GBS disease
Clinical diagnosis of chorioamnionitis
Management of previous GBS colonisation in a previous pregnancy
Collect swab between 35-37 weeks or 3-5 weeks before expected delivery
If positive then offer IAP
GBS antibiotic choice (no allergy)
Benzylpenicillin if no chorioamnionitis
Add gentamicin if clinical chorioamnionitis
GBS treatment (mild penicillin allergy)
Cephalosporin with GBS activity with caution if no chorioamnionitis
Cephalosporin with metronidazole if clinical chorioamnionitis
GBS treatment (severe penicillin allergy)
Vancomycin or sensitivity guided choice if no chorioamnionitis
Vancomycin + gentamicin + metronidazole if clinical chorioamnionitis
When to deliver PPROM with GBS?
34-37 weeks
Incidence of early onset GBS disease
0.57/1000
Risk of disability with early onset GBS disease
7.4%
Recurrent GBS carriage in subsequent pregnancy risk
50%
Risk of early onset GBS if positive swab in a subsequent pregnancy
1 in 400
Incidence of early onset GBS if negative swab in subsequent pregnancy
1 in 5000